Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 353
interventional 281
Observational 67
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 164
Drug|Other 25
Biological|Drug 10
Drug|placebo 10
Biological|Other 9
Biological 8
Drug|Other|Procedure|Radiation 5
Other 5
Biological|Drug|Procedure|Radiation 4
Drug|Procedure 4
Drug|Radiation 4
Biological|Drug|Other 3
Biological|Drug|Other|Procedure|Radiation 3
Device 3
Drug|Genetic|Other 3
Drug|Other|Procedure 2
Behavioral 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Drug|Genetic|Other 1
Biological|Drug|Other|Procedure 1
Biological|Other|Procedure 1
Biological|Procedure|Radiation 1
Device|Drug 1
Device|Other 1
Dietary Supplement|Drug 1
Dietary Supplement|Other 1
Drug|Genetic 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|Radiation 1
Drug|placebo|Procedure 1
Drug|Procedure|Radiation 1
Genetic 1
Other|Procedure 1
Other|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 144
NA 30
China 9
Netherlands 8
Korea, Republic of 7
France 5
United States|Canada 5
United States|Italy 5
Spain 4
United Kingdom 4
Germany 3
Japan 3
United States|Germany|Italy 3
Austria 2
Belgium 2
Belgium|Netherlands 2
Egypt 2
India 2
Italy 2
Sweden 2
Australia 1
Austria|Belgium|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Romania|Spain|Switzerland|Turkey|United Kingdom 1
Austria|Belgium|France|Germany|Greece|Italy|Japan|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Hungary|Ireland|Italy|Portugal|Romania|Russian Federation|Saudi Arabia|Spain|Sweden|United Kingdom 1
Austria|Germany|Israel|Italy|Switzerland|United Kingdom 1
Belgium|Czechia|France|Germany|Netherlands|Slovakia 1
Belgium|France|Germany|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Germany|Israel 1
Belgium|Switzerland 1
Brazil 1
Canada 1
Canada|Czech Republic|Egypt|France|Greece|Jordan|Portugal|Russian Federation|Spain|Switzerland|Turkey|United Kingdom 1
Kenya 1
Spain|Switzerland 1
Taiwan 1
Thailand 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|Egypt|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Russian Federation|Spain|Switzerland|Thailand|Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|France|Germany|Hungary|India|Israel|Italy|Lebanon|Malaysia|Mexico|New Zealand|Philippines|Russian Federation|Singapore|South Africa|Spain|Switzerland|Thailand 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Egypt|France|Germany|India|Israel|Korea, Republic of|Lebanon|Mexico|Poland|Russian Federation|South Africa|Thailand 1
United States|Australia|Austria|Belgium|Brazil|France|Germany|Italy|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Germany|Netherlands|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Germany|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Belgium|Bulgaria|Greece|Israel|Italy|Korea, Republic of|Spain 1
United States|Australia|Belgium|Canada|France|Italy|Spain|United Kingdom 1
United States|Australia|Belgium|Israel|Netherlands|Russian Federation|Spain 1
United States|Australia|France|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Turkey 1
United States|Austria|Germany|Netherlands|Spain|United Kingdom 1
United States|Belgium|Bulgaria|Canada|Greece|Hungary|Italy|Romania|Russian Federation|Spain 1
United States|Belgium|France|Italy|Spain|United Kingdom 1
United States|Canada|Puerto Rico 1
United States|El Salvador|Germany|Guatemala|Honduras 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|Germany 1
United States|India 1
United States|India|Nepal 1
United States|Tanzania 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 172
2 19
3 9
4 4
5 8
6 4
7 7
8 4
9 2
10 3
11 5
12 4
13 1
14 2
16 1
17 1
19 1
20 3
21 2
23 2
24 1
25 1
26 1
27 1
28 1
30 2
32 1
33 2
34 1
35 1
36 1
41 1
43 1
47 1
49 2
56 1
62 1
63 1
73 1
84 1
97 1
107 1
113 1
179 1

Phase

Phase Study_Count
Phase 2 81
Phase 1 66
Phase 3 55
Phase 4 34
N/A 26
Phase 1/Phase 2 16
Phase 2/Phase 3 2
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 130
2 82
3 14
4 3
5 2
6 1
9 1
10 1
NA 47

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 33 5.00 2.00000 5.00000 4.00000 80 20.0000 7.00000
1st Qu. 33 29.75 20.00000 25.00000 30.00000 85 100.0000 20.00000
Median 33 90.00 32.50000 33.00000 49.50000 90 218.0000 55.50000
Mean 33 193.75 44.24242 42.53333 68.48718 90 283.3208 80.44118
3rd Qu. 33 242.00 58.50000 50.50000 95.50000 95 478.0000 100.00000
Max. 33 900.00 279.00000 124.00000 260.00000 100 800.0000 500.00000

Trial Group Type

group_type Group_Count
Experimental 284
Active Comparator 63
NA 47
Other 17
No Intervention 10
Placebo Comparator 9

Intervention Model

intervention_model Study_Count
Single Group Assignment 150
Parallel Assignment 91
NA 23
Crossover Assignment 10
Sequential Assignment 7

Primary Purpose

primary_purpose Study_Count
Treatment 205
Prevention 35
Supportive Care 17
Other 8
Basic Science 6
Diagnostic 6
NA 4

Observational Studies

Studies by Country

Country Study_Count
United States 24
NA 10
France 6
India 4
Netherlands 4
China 3
Germany 2
Italy 2
Russian Federation 2
Australia 1
Austria 1
Austria|Netherlands|Russian Federation 1
Iran, Islamic Republic of 1
Israel 1
Pakistan 1
Spain 1
Switzerland 1
Taiwan 1
United States|Argentina|Australia|Brazil|China|Japan|United Kingdom 1

Sites per Study

Site_count Study_Count
1 50
2 3
3 1
4 2
5 1
6 2
7 1
11 1
13 2
17 1
23 1
27 1
56 1

Enrollment Metrics

Measure Observational
Min 8.000
1st Qu 57.250
Median 257.000
Mean 1149.242
3rd Qu 806.000
Max 40110.000

Observation Model

observational_model Study_Count
Cohort 33
Case-Only 14
NA 8
Case-Control 4
Other 4
Case Control 3
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 52
Retrospective 11
Cross-Sectional 2
NA 2

Registries

Studies by Country

Country Study_Count
United States 2
China 1
Hong Kong|Korea, Republic of|Singapore|Taiwan|Thailand 1
Italy 1

Sites per Study

Site_count Study_Count
1 1
14 1
16 1
23 1
36 1

Enrollment Metrics

Measure Registries
Min 120.0
1st Qu 300.0
Median 550.0
Mean 600.4
3rd Qu 800.0
Max 1232.0

Registry Model

observational_model Study_Count
Cohort 3
Case-Only 2

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
12 Months 1
2 Years 1
3 Months 1
30 Days 1
4 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03398161 Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03398161 Recruiting M.D. Anderson Cancer Center 2020-09-30
NCT03385226 A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) https://ClinicalTrials.gov/show/NCT03385226 Recruiting University College, London 2022-01-31
NCT03923010 A Study of Itraconazole in the Management of Superficial Fungal Infections in India https://ClinicalTrials.gov/show/NCT03923010 Recruiting Janssen Research & Development, LLC 2020-07-16
NCT03390374 Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants https://ClinicalTrials.gov/show/NCT03390374 Completed Dr Cipto Mangunkusumo General Hospital 2012-11-30
NCT03380026 Mechlorethamine Induced Contact Dermatitis Avoidance Study https://ClinicalTrials.gov/show/NCT03380026 Recruiting Rochester Skin Lymphoma Medical Group, PLLC 2019-12-13
NCT02811783 Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL https://ClinicalTrials.gov/show/NCT02811783 Recruiting Elorac, Inc. 2022-06-30
NCT03357224 PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) https://ClinicalTrials.gov/show/NCT03357224 Recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-09-30
NCT03336502 Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) https://ClinicalTrials.gov/show/NCT03336502 Completed Merck Sharp & Dohme Corp. 2018-11-26
NCT03318159 Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients https://ClinicalTrials.gov/show/NCT03318159 Recruiting Seoul National University Hospital 2019-06-30
NCT03278782 Study of Pembrolizumab (MK-3475) in Combination With Romidepsin https://ClinicalTrials.gov/show/NCT03278782 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT01805037 Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas https://ClinicalTrials.gov/show/NCT01805037 Active, not recruiting Northwestern University 2021-01-31
NCT03059992 Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment https://ClinicalTrials.gov/show/NCT03059992 Recruiting Scynexis, Inc. 2021-09-30
NCT03063632 Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma https://ClinicalTrials.gov/show/NCT03063632 Active, not recruiting National Cancer Institute (NCI) 2021-05-01
NCT03017820 VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma https://ClinicalTrials.gov/show/NCT03017820 Recruiting Mayo Clinic 2021-01-15
NCT03011814 Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma https://ClinicalTrials.gov/show/NCT03011814 Recruiting City of Hope Medical Center 2023-03-08
NCT03005353 Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories. https://ClinicalTrials.gov/show/NCT03005353 Completed Assiut University 2019-10-31
NCT02978625 Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers https://ClinicalTrials.gov/show/NCT02978625 Recruiting National Cancer Institute (NCI) 2021-06-01
NCT02971007 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) https://ClinicalTrials.gov/show/NCT02971007 Completed Matinas BioPharma Nanotechnologies, Inc. 2017-05-31
NCT02968134 Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients https://ClinicalTrials.gov/show/NCT02968134 Completed Royal Brisbane and Women’s Hospital 2017-05-21
NCT02957929 Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally https://ClinicalTrials.gov/show/NCT02957929 Completed Amplyx Pharmaceuticals 2017-04-20
NCT02956499 Safety, Tolerability and Pharmacokinetics of APX001 Administered Intravenously https://ClinicalTrials.gov/show/NCT02956499 Completed Amplyx Pharmaceuticals 2017-07-31
NCT02912156 Pharmacokinetics of Two Different Formulation of Voriconazole https://ClinicalTrials.gov/show/NCT02912156 Completed Yung Shin Pharm. Ind. Co., Ltd. 2016-07-31
NCT02805946 Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT02805946 Completed Radboud University 2019-07-26
NCT02734862 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension https://ClinicalTrials.gov/show/NCT02734862 Completed Cidara Therapeutics Inc. 2019-06-30
NCT02733432 RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections https://ClinicalTrials.gov/show/NCT02733432 Completed Cidara Therapeutics Inc. 2016-11-23
NCT02631954 Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02631954 Completed Chong Kun Dang Pharmaceutical 2015-10-31
NCT02582177 Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis https://ClinicalTrials.gov/show/NCT02582177 Recruiting Ache Laboratorios Farmaceuticos S.A. 2019-12-13
NCT02542124 NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) https://ClinicalTrials.gov/show/NCT02542124 Active, not recruiting Neumedicines Inc. 2019-02-28
NCT02520791 Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma https://ClinicalTrials.gov/show/NCT02520791 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT02493738 A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02493738 Completed Boryung Pharmaceutical Co., Ltd 2015-10-31
NCT02387983 Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) https://ClinicalTrials.gov/show/NCT02387983 Completed Merck Sharp & Dohme Corp. 2016-05-02
NCT02343627 Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail https://ClinicalTrials.gov/show/NCT02343627 Completed Taro Pharmaceuticals USA 2016-01-31
NCT02341209 Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT02341209 Recruiting Rochester General Hospital 2020-02-06
NCT02244606 Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis https://ClinicalTrials.gov/show/NCT02244606 Completed Scynexis, Inc. 2016-06-30
NCT02243579 Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome https://ClinicalTrials.gov/show/NCT02243579 Completed National Cancer Institute (NCI) 2018-01-04
NCT02232516 Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT02232516 Recruiting Northwestern University 2022-07-31
NCT02227797 MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients https://ClinicalTrials.gov/show/NCT02227797 Completed Masonic Cancer Center, University of Minnesota 2017-09-08
NCT01578499 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician’s Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) https://ClinicalTrials.gov/show/NCT01578499 Completed Takeda 2016-05-31
NCT04039880 Absorption, Metabolism and Excretion of 14C-olorofim in Man https://ClinicalTrials.gov/show/NCT04039880 Completed F2G Ltd. 2019-09-30
NCT02180165 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) https://ClinicalTrials.gov/show/NCT02180165 Completed Merck Sharp & Dohme Corp. 2018-01-24
NCT02172768 Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease https://ClinicalTrials.gov/show/NCT02172768 Completed Radboud University 2016-06-30
NCT02168140 CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT02168140 Active, not recruiting Wake Forest University Health Sciences 2019-04-18
NCT02154178 Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE) https://ClinicalTrials.gov/show/NCT02154178 Completed University Hospital, Lille 2016-10-31
NCT02079298 Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants https://ClinicalTrials.gov/show/NCT02079298 Completed Karolinska Institutet 2015-09-30
NCT01318148 Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis https://ClinicalTrials.gov/show/NCT01318148 Completed Wuerzburg University Hospital 2013-09-30
NCT01307930 Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations https://ClinicalTrials.gov/show/NCT01307930 Completed Texas Tech University Health Sciences Center 2012-11-30
NCT01307579 Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01307579 Active, not recruiting Children’s Oncology Group 2018-06-30
NCT01303549 Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients https://ClinicalTrials.gov/show/NCT01303549 Completed Fundacion SEIMC-GESIDA 2014-05-31
NCT01273766 Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01273766 Completed Wake Forest University Health Sciences 2012-03-31
NCT01288378 Empirical Versus Preemptive Antifungal Therapy https://ClinicalTrials.gov/show/NCT01288378 Completed European Organisation for Research and Treatment of Cancer - EORTC 2019-04-04
NCT03810196 CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT https://ClinicalTrials.gov/show/NCT03810196 Recruiting Children’s Hospital of Philadelphia 2024-01-31
NCT01968395 Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure https://ClinicalTrials.gov/show/NCT01968395 Completed Erasme University Hospital 2014-08-31
NCT01959477 Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01959477 Completed Case Comprehensive Cancer Center 2015-01-31
NCT01916057 Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis https://ClinicalTrials.gov/show/NCT01916057 Completed Assistance Publique - Hôpitaux de Paris 2017-06-01
NCT01888458 Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) https://ClinicalTrials.gov/show/NCT01888458 Completed Nantes University Hospital 2016-04-30
NCT01839916 Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01839916 Completed University of Chicago 2018-08-31
NCT01823289 An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections https://ClinicalTrials.gov/show/NCT01823289 Completed Xian-Janssen Pharmaceutical Ltd. 2008-12-31
NCT01800838 Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01800838 Completed Case Comprehensive Cancer Center 2014-09-30
NCT01782131 A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) https://ClinicalTrials.gov/show/NCT01782131 Completed Merck Sharp & Dohme Corp. 2019-07-10
NCT01777763 Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) https://ClinicalTrials.gov/show/NCT01777763 Completed Merck Sharp & Dohme Corp. 2012-02-29
NCT01772212 Bioequivalence Study for Terbinafine 250 mg https://ClinicalTrials.gov/show/NCT01772212 Completed GlaxoSmithKline 2011-03-15
NCT01748721 MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT01748721 Completed Morphotek 2015-05-31
NCT01724229 Clinical Case Series Evaluating Skin Wellness System https://ClinicalTrials.gov/show/NCT01724229 Completed GM Associates 2013-06-30
NCT01686594 PUVA Maintenance Therapy in Mycosis Fungoides https://ClinicalTrials.gov/show/NCT01686594 Completed Medical University of Graz 2018-07-02
NCT01678443 Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies https://ClinicalTrials.gov/show/NCT01678443 Active, not recruiting Fred Hutchinson Cancer Research Center 2011-04-11
NCT01658319 Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01658319 Completed Case Comprehensive Cancer Center 2015-02-28
NCT01657201 Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend) https://ClinicalTrials.gov/show/NCT01657201 Completed Samyang Biopharmaceuticals Corporation 2012-11-30
NCT01590732 Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT01590732 Completed M.D. Anderson Cancer Center 2018-05-02
NCT01588015 Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01588015 Active, not recruiting City of Hope Medical Center 2021-11-30
NCT01576653 Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL https://ClinicalTrials.gov/show/NCT01576653 Recruiting Medical University of Graz 2019-06-30
NCT01567709 Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT01567709 Completed National Cancer Institute (NCI) 2018-03-29
NCT01529827 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01529827 Completed Roswell Park Cancer Institute 2015-05-28
NCT01523223 Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies https://ClinicalTrials.gov/show/NCT01523223 Completed Stanford University 2016-09-30
NCT01503515 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01503515 Active, not recruiting Children’s Oncology Group 2019-12-31
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01484015 Completed Wake Forest University Health Sciences 2012-06-30
NCT01427881 Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01427881 Completed Fred Hutchinson Cancer Research Center 2014-06-30
NCT03602157 Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL https://ClinicalTrials.gov/show/NCT03602157 Recruiting UNC Lineberger Comprehensive Cancer Center 2026-09-30
NCT01416025 A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing https://ClinicalTrials.gov/show/NCT01416025 Completed Johns Hopkins University 2014-12-31
NCT03159364 Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections https://ClinicalTrials.gov/show/NCT03159364 Recruiting Shenzhen Geno-Immune Medical Institute 2020-07-31
NCT01396070 Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level https://ClinicalTrials.gov/show/NCT01396070 Completed Stanford University 2015-04-30
NCT01384513 A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01384513 Recruiting Thomas Jefferson University 2020-12-31
NCT01371656 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01371656 Completed Children’s Oncology Group 2017-06-30
NCT01352520 SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) https://ClinicalTrials.gov/show/NCT01352520 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT01326702 Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors https://ClinicalTrials.gov/show/NCT01326702 Completed National Cancer Institute (NCI) 2015-04-30
NCT00353158 A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity https://ClinicalTrials.gov/show/NCT00353158 Completed National Institutes of Health Clinical Center (CC) 2011-09-20
NCT04368559 Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation https://ClinicalTrials.gov/show/NCT04368559 Recruiting Cidara Therapeutics Inc. 2022-03-31
NCT04307082 ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT04307082 Active, not recruiting Scynexis, Inc. 2020-05-29
NCT04273178 Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT04273178 Recruiting Shanghai Jiao Tong University School of Medicine 2022-01-15
NCT04265521 Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet https://ClinicalTrials.gov/show/NCT04265521 Recruiting Biocool AB 2020-06-25
NCT04240886 An Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds https://ClinicalTrials.gov/show/NCT04240886 Recruiting Amplyx Pharmaceuticals 2021-07-31
NCT04238884 Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy https://ClinicalTrials.gov/show/NCT04238884 Recruiting Instituto de Investigación Hospital Universitario La Paz 2020-01-18
NCT04256018 Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome https://ClinicalTrials.gov/show/NCT04256018 Recruiting Stanford University 2022-02-28
NCT04185220 Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome https://ClinicalTrials.gov/show/NCT04185220 Recruiting National Institutes of Health Clinical Center (CC) 2023-03-01
NCT02822586 TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome https://ClinicalTrials.gov/show/NCT02822586 Completed Virginia Commonwealth University 2019-04-29
NCT04166669 A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 https://ClinicalTrials.gov/show/NCT04166669 Completed Amplyx Pharmaceuticals 2020-03-03
NCT04157465 Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients https://ClinicalTrials.gov/show/NCT04157465 Recruiting Postgraduate Institute of Medical Education and Research 2020-12-31
NCT04122560 Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration https://ClinicalTrials.gov/show/NCT04122560 Recruiting Radboud University 2020-08-01
NCT04101331 Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides https://ClinicalTrials.gov/show/NCT04101331 Recruiting Affimed GmbH 2022-04-30
NCT03857399 Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin https://ClinicalTrials.gov/show/NCT03857399 Recruiting Cttq 2019-09-30
NCT04035187 Itraconazole Oral Absorption https://ClinicalTrials.gov/show/NCT04035187 Recruiting University of Maryland, Baltimore 2020-09-01
NCT03941951 Study to Optimize the Use of New Antibiotics https://ClinicalTrials.gov/show/NCT03941951 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2020-12-31
NCT03905135 Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies https://ClinicalTrials.gov/show/NCT03905135 Recruiting National Institutes of Health Clinical Center (CC) 2022-03-01
NCT03902184 IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma https://ClinicalTrials.gov/show/NCT03902184 Recruiting Innate Pharma 2022-03-01
NCT03837457 PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study https://ClinicalTrials.gov/show/NCT03837457 Enrolling by invitation miRagen Therapeutics, Inc. 2021-12-31
NCT03828773 PTX3-targeted Antifungal Prophylaxis https://ClinicalTrials.gov/show/NCT03828773 Recruiting Centre Hospitalier Universitaire Vaudois 2022-07-31
NCT03814343 Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis https://ClinicalTrials.gov/show/NCT03814343 Recruiting Mahidol University 2020-01-15
NCT03760276 A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen https://ClinicalTrials.gov/show/NCT03760276 Completed Seoul National University Hospital 2018-10-28
NCT03717623 Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants https://ClinicalTrials.gov/show/NCT03717623 Recruiting Melbourne Health 2020-06-30
NCT03713320 SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03713320 Active, not recruiting miRagen Therapeutics, Inc. 2021-04-30
NCT03695471 Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03695471 Recruiting Mayo Clinic 2022-10-11
NCT03598998 Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas https://ClinicalTrials.gov/show/NCT03598998 Recruiting City of Hope Medical Center 2021-04-27
NCT03587844 Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients https://ClinicalTrials.gov/show/NCT03587844 Recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT03583164 Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options https://ClinicalTrials.gov/show/NCT03583164 Recruiting F2G Ltd. 2020-12-31
NCT03577509 Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China https://ClinicalTrials.gov/show/NCT03577509 Completed CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 2018-09-14
NCT03572049 Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole https://ClinicalTrials.gov/show/NCT03572049 Recruiting University of Alabama at Birmingham 2020-05-31
NCT03471988 Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis https://ClinicalTrials.gov/show/NCT03471988 Recruiting Asahi Kasei Pharma Corporation 2021-12-31
NCT03454945 Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03454945 Recruiting Cairo University 2019-04-01
NCT03434704 Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole https://ClinicalTrials.gov/show/NCT03434704 Recruiting IRCCS San Raffaele 2020-03-15
NCT01259713 Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01259713 Completed Gilead Sciences 2013-12-31
NCT01258998 Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma https://ClinicalTrials.gov/show/NCT01258998 Completed National Cancer Institute (NCI) 2014-07-31
NCT01254578 Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers https://ClinicalTrials.gov/show/NCT01254578 Completed National Cancer Institute (NCI) 2012-11-09
NCT01233921 Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT01233921 Completed Fred Hutchinson Cancer Research Center 2012-07-31
NCT01232504 Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT https://ClinicalTrials.gov/show/NCT01232504 Completed Xiamen Amoytop Biotech Co., Ltd. 2013-03-31
NCT01231919 MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia https://ClinicalTrials.gov/show/NCT01231919 Completed National Cancer Institute (NCI) 2013-04-30
NCT01261247 Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01261247 Active, not recruiting Mayo Clinic 2016-05-09
NCT01200355 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01200355 Completed Memorial Sloan Kettering Cancer Center 2017-04-20
NCT01198236 Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection https://ClinicalTrials.gov/show/NCT01198236 Completed Zhejiang University 2010-09-30
NCT01177371 High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01177371 Completed Case Comprehensive Cancer Center 2000-02-29
NCT01169402 Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO) https://ClinicalTrials.gov/show/NCT01169402 Completed Duke University 2013-02-20
NCT01158274 RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT01158274 Completed National Cancer Institute (NCI) 2012-08-31
NCT01134341 Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma https://ClinicalTrials.gov/show/NCT01134341 Completed Acrotech Biopharma LLC 2015-08-31
NCT01129193 AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma https://ClinicalTrials.gov/show/NCT01129193 Completed Ohio State University Comprehensive Cancer Center 2017-01-07
NCT01129180 Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT01129180 Completed Ohio State University Comprehensive Cancer Center 2012-05-31
NCT01122368 A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects https://ClinicalTrials.gov/show/NCT01122368 Completed Astellas Pharma Inc 2011-12-15
NCT01110135 Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma https://ClinicalTrials.gov/show/NCT01110135 Completed University of Washington 2013-11-30
NCT01093586 Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01093586 Completed Case Comprehensive Cancer Center 2015-12-31
NCT01075321 Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01075321 Active, not recruiting Mayo Clinic 2015-02-28
NCT01073267 Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides https://ClinicalTrials.gov/show/NCT01073267 Completed M.D. Anderson Cancer Center 2014-12-31
NCT01062165 Effect of Weight and/or Obesity on Caspofungin Drug Concentrations https://ClinicalTrials.gov/show/NCT01062165 Completed Texas Tech University Health Sciences Center 2010-12-31
NCT01058174 Liver Transplant European Study Into the Prevention of Fungal Infection https://ClinicalTrials.gov/show/NCT01058174 Completed Astellas Pharma Inc 2012-05-03
NCT01053494 Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer https://ClinicalTrials.gov/show/NCT01053494 Completed Wake Forest University Health Sciences 2012-02-29
NCT00997035 The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo https://ClinicalTrials.gov/show/NCT00997035 Completed University of California, San Francisco 2016-01-31
NCT00996736 Mycotic Ulcer Treatment Trial I https://ClinicalTrials.gov/show/NCT00996736 Completed University of California, San Francisco 2012-07-31
NCT00961220 O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT00961220 Completed National Cancer Institute (NCI) 2012-04-08
NCT00936117 Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia https://ClinicalTrials.gov/show/NCT00936117 Completed M.D. Anderson Cancer Center 2013-09-30
NCT00918333 Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00918333 Completed Mayo Clinic 2015-12-01
NCT00077155 Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00077155 Completed National Cancer Institute (NCI) 2010-06-30
NCT00904995 Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis https://ClinicalTrials.gov/show/NCT00904995 Completed M.D. Anderson Cancer Center 2010-07-31
NCT00896493 Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma https://ClinicalTrials.gov/show/NCT00896493 Active, not recruiting Stanford University 2022-12-31
NCT00893555 Pharmacologic Optimization of Voriconazole https://ClinicalTrials.gov/show/NCT00893555 Completed University Medical Center Groningen 2016-11-30
NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00890747 Completed National Cancer Institute (NCI) 2011-05-31
NCT00890708 Therapeutic Drug Monitoring of Voriconazole https://ClinicalTrials.gov/show/NCT00890708 Completed Seoul National University Hospital 2011-12-31
NCT00856388 Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders https://ClinicalTrials.gov/show/NCT00856388 Completed Roswell Park Cancer Institute 2012-08-09
NCT00842504 Alternate Day Micafungin: A PK Study in Pediatric Patients https://ClinicalTrials.gov/show/NCT00842504 Completed Children’s Hospital Medical Center, Cincinnati 2009-12-31
NCT00841971 Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT00841971 Completed University of Pittsburgh 2013-07-31
NCT02652715 Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT02652715 Completed Mayo Clinic 2018-12-21
NCT02851680 Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia. https://ClinicalTrials.gov/show/NCT02851680 Completed Centre Hospitalier Universitaire Dijon 2015-05-31
NCT01383993 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection https://ClinicalTrials.gov/show/NCT01383993 Completed Pfizer 2013-05-31
NCT01075984 Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) https://ClinicalTrials.gov/show/NCT01075984 Completed Merck Sharp & Dohme Corp. 2012-11-20
NCT01760655 Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01760655 Recruiting Thomas Jefferson University 2021-03-31
NCT00811928 Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) https://ClinicalTrials.gov/show/NCT00811928 Completed Merck Sharp & Dohme Corp. 2010-05-31
NCT00811642 Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) https://ClinicalTrials.gov/show/NCT00811642 Completed Merck Sharp & Dohme Corp. 2010-03-31
NCT03731169 CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels https://ClinicalTrials.gov/show/NCT03731169 Recruiting University Health Network, Toronto 2019-06-30
NCT03281811 Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03281811 Active, not recruiting Mayo Clinic 2020-02-25
NCT02580552 Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL https://ClinicalTrials.gov/show/NCT02580552 Active, not recruiting miRagen Therapeutics, Inc. 2020-12-31
NCT03667690 Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis https://ClinicalTrials.gov/show/NCT03667690 Recruiting Cidara Therapeutics Inc. 2020-09-30
NCT02358499 Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children https://ClinicalTrials.gov/show/NCT02358499 Completed Children’s Mercy Hospital Kansas City 2018-12-31
NCT01419678 Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients https://ClinicalTrials.gov/show/NCT01419678 Completed University of Pittsburgh 2014-12-31
NCT00936910 Antifungal Locks to Treat Fungal-related Central Line Infections https://ClinicalTrials.gov/show/NCT00936910 Completed University of Pittsburgh 2010-08-31
NCT02953301 Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) https://ClinicalTrials.gov/show/NCT02953301 Recruiting 4SC AG 2022-01-31
NCT00794703 A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections https://ClinicalTrials.gov/show/NCT00794703 Completed Astellas Pharma Inc 2009-11-30
NCT00784368 A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection https://ClinicalTrials.gov/show/NCT00784368 Completed Janssen Pharmaceutical K.K. 2009-04-30
NCT00769288 FAU in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00769288 Completed National Cancer Institute (NCI) 2013-12-31
NCT00750737 Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) https://ClinicalTrials.gov/show/NCT00750737 Completed M.D. Anderson Cancer Center 2012-06-30
NCT00748319 Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma https://ClinicalTrials.gov/show/NCT00748319 Completed Assistance Publique - Hôpitaux de Paris 2011-11-30
NCT00740389 TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. https://ClinicalTrials.gov/show/NCT00740389 Completed Tibotec Pharmaceuticals, Ireland 2009-01-31
NCT00739934 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection https://ClinicalTrials.gov/show/NCT00739934 Completed Pfizer 2009-10-31
NCT00734500 Anidulafungin PK in Infants and Toddlers https://ClinicalTrials.gov/show/NCT00734500 Completed Duke University 2010-06-30
NCT00717860 A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) https://ClinicalTrials.gov/show/NCT00717860 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT00686543 Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) https://ClinicalTrials.gov/show/NCT00686543 Completed Merck Sharp & Dohme Corp. 2009-04-30
NCT00647907 A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections https://ClinicalTrials.gov/show/NCT00647907 Completed Pfizer NA
NCT00635648 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) https://ClinicalTrials.gov/show/NCT00635648 Completed Merck Sharp & Dohme Corp. 2011-05-31
NCT00634049 Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi https://ClinicalTrials.gov/show/NCT00634049 Completed Astellas Pharma Inc 2014-01-03
NCT00611208 A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) https://ClinicalTrials.gov/show/NCT00611208 Completed Angimmune LLC 2015-02-28
NCT00608361 Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00608361 Completed National Cancer Institute (NCI) 2014-08-31
NCT00606268 A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00606268 Completed Astellas Pharma Inc 2009-03-31
NCT00601718 Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma https://ClinicalTrials.gov/show/NCT00601718 Completed University of Washington 2010-06-30
NCT00550732 A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) https://ClinicalTrials.gov/show/NCT00550732 Completed Merck Sharp & Dohme Corp. 2012-11-30
NCT00548080 Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) https://ClinicalTrials.gov/show/NCT00548080 Completed Merck Sharp & Dohme Corp. 2006-11-30
NCT00535470 An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00535470 Completed Yaupon Therapeutics 2011-03-31
NCT00509938 Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients https://ClinicalTrials.gov/show/NCT00509938 Completed AM-Pharma 2006-11-30
NCT00499811 Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00499811 Completed National Cancer Institute (NCI) 2011-08-31
NCT00489203 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00489203 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00466921 Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome https://ClinicalTrials.gov/show/NCT00466921 Active, not recruiting Northwestern University 2020-02-29
NCT00458731 Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma https://ClinicalTrials.gov/show/NCT00458731 Completed National Cancer Institute (NCI) 2013-12-31
NCT00418951 Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00418951 Completed M.D. Anderson Cancer Center 2009-10-31
NCT00413218 Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections https://ClinicalTrials.gov/show/NCT00413218 Completed Astellas Pharma Inc 2015-03-03
NCT00412893 Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis https://ClinicalTrials.gov/show/NCT00412893 Completed Astellas Pharma Inc 2013-03-28
NCT00386802 Antifungal Use in Oncohematological Neutropenic Patients https://ClinicalTrials.gov/show/NCT00386802 Completed PETHEMA Foundation 2008-12-31
NCT00379964 A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) https://ClinicalTrials.gov/show/NCT00379964 Completed Merck Sharp & Dohme Corp. 2006-05-31
NCT00348985 PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00348985 Completed National Cancer Institute (NCI) 2010-01-31
NCT00336531 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00336531 Completed Samsung Medical Center 2008-06-30
NCT00326157 PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00326157 Completed Gilead Sciences 2009-01-31
NCT00300677 To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days https://ClinicalTrials.gov/show/NCT00300677 Completed Pfizer 2008-08-31
NCT00293345 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00293345 Completed National Cancer Institute (NCI) 2012-10-31
NCT00292071 Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) https://ClinicalTrials.gov/show/NCT00292071 Completed Merck Sharp & Dohme Corp. 2006-07-31
NCT00289991 Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) https://ClinicalTrials.gov/show/NCT00289991 Completed Pfizer 2009-02-28
NCT00288197 A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections https://ClinicalTrials.gov/show/NCT00288197 Completed Pfizer 2007-06-30
NCT00229060 Doripenem in the Treatment of Complicated Intra-Abdominal Infections https://ClinicalTrials.gov/show/NCT00229060 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00221039 Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A https://ClinicalTrials.gov/show/NCT00221039 Completed M.D. Anderson Cancer Center 2011-04-05
NCT00210938 Doripenem in the Treatment of Complicated Intra-Abdominal Infections https://ClinicalTrials.gov/show/NCT00210938 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00148148 A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation https://ClinicalTrials.gov/show/NCT00148148 Completed University Hospital Muenster NA
NCT00185965 CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas https://ClinicalTrials.gov/show/NCT00185965 Completed Stanford University 2010-03-31
NCT00178841 Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL https://ClinicalTrials.gov/show/NCT00178841 Completed Vanderbilt University 2007-03-31
NCT00177710 Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study https://ClinicalTrials.gov/show/NCT00177710 Completed University of Pittsburgh NA
NCT00177684 Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) https://ClinicalTrials.gov/show/NCT00177684 Completed University of Pittsburgh NA
NCT00170430 Reducing Vaginal Infections in Women https://ClinicalTrials.gov/show/NCT00170430 Completed University of Washington 2006-12-31
NCT00168064 Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00168064 Completed Yaupon Therapeutics 2010-08-31
NCT00158730 Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment https://ClinicalTrials.gov/show/NCT00158730 Completed Gilead Sciences NA
NCT00150345 Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients https://ClinicalTrials.gov/show/NCT00150345 Completed Pfizer 2009-04-30
NCT00143312 Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants https://ClinicalTrials.gov/show/NCT00143312 Completed Pfizer 2008-04-30
NCT00136968 Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy https://ClinicalTrials.gov/show/NCT00136968 Completed Pfizer NA
NCT00118352 Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00118352 Completed Fred Hutchinson Cancer Research Center 2010-07-31
NCT00112593 Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer https://ClinicalTrials.gov/show/NCT00112593 Completed Fred Hutchinson Cancer Research Center 2014-11-30
NCT00002479 Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome https://ClinicalTrials.gov/show/NCT00002479 Completed Northwestern University 2002-08-31
NCT00103246 Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen’s Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00103246 Completed Case Comprehensive Cancer Center 2008-12-31
NCT00098891 MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00098891 Completed National Cancer Institute (NCI) 2008-03-31
NCT00091559 Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) https://ClinicalTrials.gov/show/NCT00091559 Completed Merck Sharp & Dohme Corp. 2005-11-23
NCT00003315 Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection https://ClinicalTrials.gov/show/NCT00003315 Completed National Cancer Institute (NCI) NA
NCT00089271 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00089271 Completed National Cancer Institute (NCI) 2010-06-30
NCT00089011 Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00089011 Completed Fred Hutchinson Cancer Research Center 2014-03-31
NCT00003196 Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma https://ClinicalTrials.gov/show/NCT00003196 Completed Fred Hutchinson Cancer Research Center 2002-04-30
NCT00006251 Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer https://ClinicalTrials.gov/show/NCT00006251 Completed Fred Hutchinson Cancer Research Center 2005-09-30
NCT00074087 Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00074087 Completed European Organisation for Research and Treatment of Cancer - EORTC 2009-07-31
NCT00005080 506U78 in Treating Patients With Lymphoma https://ClinicalTrials.gov/show/NCT00005080 Completed National Cancer Institute (NCI) 2006-01-31
NCT00005799 Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer https://ClinicalTrials.gov/show/NCT00005799 Completed Fred Hutchinson Cancer Research Center 2002-07-31
NCT00078858 Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00078858 Completed Fred Hutchinson Cancer Research Center 2006-01-31
NCT00075803 Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) https://ClinicalTrials.gov/show/NCT00075803 Completed Medical College of Wisconsin 2006-09-30
NCT02306330 MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial https://ClinicalTrials.gov/show/NCT02306330 Completed Oxford University Clinical Research Unit, Vietnam 2016-01-31
NCT00072514 Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies https://ClinicalTrials.gov/show/NCT00072514 Completed Fred Hutchinson Cancer Research Center 2008-07-31
NCT00003210 Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin’s Lymphoma or Hodgkin’s Disease https://ClinicalTrials.gov/show/NCT00003210 Completed National Cancer Institute (NCI) 2003-11-30
NCT00066664 Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin https://ClinicalTrials.gov/show/NCT00066664 Completed National Institutes of Health Clinical Center (CC) 2007-12-31
NCT00066599 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT00066599 Completed National Cancer Institute (NCI) NA
NCT00064311 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00064311 Completed National Institutes of Health Clinical Center (CC) NA
NCT00795769 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00795769 Completed Fred Hutchinson Cancer Research Center 2009-06-09
NCT00059878 Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections https://ClinicalTrials.gov/show/NCT00059878 Completed National Cancer Institute (NCI) NA
NCT00057967 Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome https://ClinicalTrials.gov/show/NCT00057967 Completed Northwestern University 2007-06-26
NCT00049504 Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer https://ClinicalTrials.gov/show/NCT00049504 Completed Fred Hutchinson Cancer Research Center 2011-03-31
NCT00047060 Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome https://ClinicalTrials.gov/show/NCT00047060 Completed National Institutes of Health Clinical Center (CC) 2019-01-24
NCT00040846 Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT00040846 Completed Fred Hutchinson Cancer Research Center 2009-12-31
NCT00025415 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00025415 Completed National Cancer Institute (NCI) 2005-01-31
NCT00051012 Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients https://ClinicalTrials.gov/show/NCT00051012 Completed Eisai Inc. 2006-10-31
NCT00014235 Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00014235 Completed Fred Hutchinson Cancer Research Center 2005-02-28
NCT00004241 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma https://ClinicalTrials.gov/show/NCT00004241 Completed National Cancer Institute (NCI) 2006-05-31
NCT00003970 Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00003970 Completed National Cancer Institute (NCI) 2003-10-31
NCT00038376 Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies https://ClinicalTrials.gov/show/NCT00038376 Completed M.D. Anderson Cancer Center 2005-06-30
NCT00002687 Interleukin-2 in Treating Patients With Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00002687 Completed University of Washington 2003-07-31
NCT00050999 Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients https://ClinicalTrials.gov/show/NCT00050999 Completed Eisai Inc. 2006-09-30
NCT00005912 Voriconazole to Prevent Systemic Fungal Infections in Children https://ClinicalTrials.gov/show/NCT00005912 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001940 Voriconazole to Treat Fungal Infections https://ClinicalTrials.gov/show/NCT00001940 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001937 Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients https://ClinicalTrials.gov/show/NCT00001937 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001810 An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00001810 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001790 Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00001790 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001757 An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00001757 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001280 Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease https://ClinicalTrials.gov/show/NCT00001280 Completed National Institutes of Health Clinical Center (CC) NA
NCT00034671 PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) https://ClinicalTrials.gov/show/NCT00034671 Completed Merck Sharp & Dohme Corp. 2001-11-30
NCT00034658 Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) https://ClinicalTrials.gov/show/NCT00034658 Completed Merck Sharp & Dohme Corp. 2002-03-31
NCT00034645 Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease https://ClinicalTrials.gov/show/NCT00034645 Completed Merck Sharp & Dohme Corp. 2003-02-28
NCT00034632 Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) https://ClinicalTrials.gov/show/NCT00034632 Completed Merck Sharp & Dohme Corp. 2007-03-31
NCT00033982 Posaconazole to Treat Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00033982 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005668 A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma https://ClinicalTrials.gov/show/NCT00005668 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00002325 A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common https://ClinicalTrials.gov/show/NCT00002325 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002277 A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections https://ClinicalTrials.gov/show/NCT00002277 Completed NIH AIDS Clinical Trials Information Service NA
NCT00817765 Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir https://ClinicalTrials.gov/show/NCT00817765 Completed Radboud University 2009-07-31
NCT00002122 A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00002122 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002038 Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy https://ClinicalTrials.gov/show/NCT00002038 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001107 Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants https://ClinicalTrials.gov/show/NCT00001107 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000826 Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites https://ClinicalTrials.gov/show/NCT00000826 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000676 Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) https://ClinicalTrials.gov/show/NCT00000676 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00408681 Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00408681 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00015665 Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00015665 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04121871 Molecular Characterization of Candida Auris https://ClinicalTrials.gov/show/NCT04121871 Recruiting Islamia University of Bahawalpur 2020-02-29
NCT02492802 Effect of Inflammation on Pharmacokinetics of Posaconazole https://ClinicalTrials.gov/show/NCT02492802 Completed University Medical Center Groningen 2017-06-01
NCT03262584 Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients https://ClinicalTrials.gov/show/NCT03262584 Completed Karius, Inc. 2018-07-31
NCT03149562 Association of Plasma Transfusions and Invasive Fungal Infection https://ClinicalTrials.gov/show/NCT03149562 Recruiting Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 2022-12-31
NCT03066011 Registry of Patients Treated With Systemic Mold-Active Triazoles https://ClinicalTrials.gov/show/NCT03066011 Completed Astellas Pharma Inc 2020-04-24
NCT02888197 Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization https://ClinicalTrials.gov/show/NCT02888197 Completed Cidara Therapeutics Inc. 2017-03-15
NCT02859831 Sautour PHRC IR 2008 https://ClinicalTrials.gov/show/NCT02859831 Completed Centre Hospitalier Universitaire Dijon 2009-02-28
NCT02848274 ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome https://ClinicalTrials.gov/show/NCT02848274 Recruiting Stanford University 2022-03-31
NCT02702310 Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides https://ClinicalTrials.gov/show/NCT02702310 Recruiting Vanderbilt-Ingram Cancer Center 2020-12-31
NCT02683642 Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome https://ClinicalTrials.gov/show/NCT02683642 Completed Fungal Infection Study Forum 2017-09-30
NCT02681458 Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran https://ClinicalTrials.gov/show/NCT02681458 Completed Islamic Azad University of Mashhad 2014-03-31
NCT02678598 A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT02678598 Completed Astellas Pharma Inc 2015-08-31
NCT02674685 Vfend Special Investigation For Prophylaxis https://ClinicalTrials.gov/show/NCT02674685 Completed Pfizer 2019-07-03
NCT02544230 Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02544230 Completed Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 2011-12-31
NCT02492594 Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT02492594 Recruiting St. Anna Kinderkrebsforschung 2019-12-05
NCT02318524 Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients https://ClinicalTrials.gov/show/NCT02318524 Completed University Hospital, Lille 2017-10-31
NCT02155114 Iron Homoeostasis in Inflammation https://ClinicalTrials.gov/show/NCT02155114 Completed University Hospital, Basel, Switzerland 2014-10-31
NCT02074462 Effect of Inflammation on Voriconazole Concentration https://ClinicalTrials.gov/show/NCT02074462 Completed University Medical Center Groningen 2014-08-31
NCT01904188 Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate? https://ClinicalTrials.gov/show/NCT01904188 Recruiting Michigan State University 2022-07-31
NCT02025699 Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis https://ClinicalTrials.gov/show/NCT02025699 Completed MeMed Diagnostics Ltd. 2016-06-30
NCT01783379 Pharmacokinetics of Micafungin in Patients Intensive Care Unit https://ClinicalTrials.gov/show/NCT01783379 Completed Radboud University 2014-03-31
NCT01781182 Infant Antibiotic Resistance and Implications for Therapeutic Decision-making https://ClinicalTrials.gov/show/NCT01781182 Completed University Hospitals Cleveland Medical Center 2017-03-31
NCT01731353 Fungiscope - A Global Emerging Fungal Infection Registry https://ClinicalTrials.gov/show/NCT01731353 Recruiting University of Cologne 2020-12-31
NCT01686607 Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents https://ClinicalTrials.gov/show/NCT01686607 Completed Astellas Pharma Inc 2018-04-30
NCT01680458 Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication https://ClinicalTrials.gov/show/NCT01680458 Completed Pfizer 2014-10-31
NCT01533558 Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates https://ClinicalTrials.gov/show/NCT01533558 Completed Radboud University 2013-05-31
NCT01436578 Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547) https://ClinicalTrials.gov/show/NCT01436578 Completed Merck Sharp & Dohme Corp. 2013-11-30
NCT01393002 Perception and Prevalence of Fungal Infections in Berlin - Brandenburg https://ClinicalTrials.gov/show/NCT01393002 Completed Charite University, Berlin, Germany 2012-07-31
NCT04287504 Point-of-care Tests for Bacterial Vaginosis and Candidosis https://ClinicalTrials.gov/show/NCT04287504 Recruiting Medical University of Vienna 2020-12-31
NCT04103840 Invasive Fungal Infections in Severe Alcohol-associated Hepatitis https://ClinicalTrials.gov/show/NCT04103840 Recruiting Postgraduate Institute of Medical Education and Research 2022-10-01
NCT04004078 An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM https://ClinicalTrials.gov/show/NCT04004078 Recruiting People’s Hospital of Zhengzhou University 2020-03-31
NCT03793231 fungalAi for Fungal Surveillance & Antifungal Stewardship https://ClinicalTrials.gov/show/NCT03793231 Enrolling by invitation Bayside Health 2020-04-30
NCT03789864 Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides https://ClinicalTrials.gov/show/NCT03789864 Recruiting Indiana University 2021-05-01
NCT03781024 A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care https://ClinicalTrials.gov/show/NCT03781024 Enrolling by invitation Data Collection Analysis Business Management 2021-12-01
NCT03731156 Granulomatous Pneumocystis Pneumonia https://ClinicalTrials.gov/show/NCT03731156 Completed University Hospital, Montpellier 2019-12-30
NCT03674359 Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia. https://ClinicalTrials.gov/show/NCT03674359 Recruiting Assistance Publique - Hôpitaux de Paris 2021-09-30
NCT03641131 Ampholipad Real-World Data in Taiwan https://ClinicalTrials.gov/show/NCT03641131 Completed Taiwan Liposome Company 2019-01-02
NCT03429023 Descriptive Epidemiology on Management of Mucormycosis https://ClinicalTrials.gov/show/NCT03429023 Completed Fungal Infection Study Forum 2017-09-30
NCT01254318 Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) https://ClinicalTrials.gov/show/NCT01254318 Completed Merck Sharp & Dohme Corp. 2014-11-30
NCT01222741 Studies of Disorders With Increased Susceptibility to Fungal Infections https://ClinicalTrials.gov/show/NCT01222741 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01151085 Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) https://ClinicalTrials.gov/show/NCT01151085 Completed Pfizer 2012-05-31
NCT01137292 Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection https://ClinicalTrials.gov/show/NCT01137292 Completed Pfizer 2009-11-30
NCT01101386 Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis https://ClinicalTrials.gov/show/NCT01101386 Completed University of Colorado, Denver 2012-11-30
NCT01073631 Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea https://ClinicalTrials.gov/show/NCT01073631 Completed Pfizer 2009-10-31
NCT01073618 Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV https://ClinicalTrials.gov/show/NCT01073618 Completed Pfizer 2009-10-31
NCT00906633 Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers https://ClinicalTrials.gov/show/NCT00906633 Completed University Hospital, Udine, Italy 2009-12-31
NCT00923832 Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis https://ClinicalTrials.gov/show/NCT00923832 Completed National Institutes of Health Clinical Center (CC) NA
NCT01519648 A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01519648 Completed National Hematological Society, Russia 2013-09-30
NCT03774316 De-escalation - Antifungal Treatment Immunocompromised Patients https://ClinicalTrials.gov/show/NCT03774316 Recruiting University Hospital, Lille 2020-09-30
NCT02823132 Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia https://ClinicalTrials.gov/show/NCT02823132 Completed Centre Hospitalier Universitaire Dijon 2015-06-30
NCT01386437 Natural History of Individuals With Immune System Problems That Lead to Fungal Infections https://ClinicalTrials.gov/show/NCT01386437 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00726609 Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) https://ClinicalTrials.gov/show/NCT00726609 Completed Merck Sharp & Dohme Corp. 2008-07-31
NCT00722189 Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses https://ClinicalTrials.gov/show/NCT00722189 Completed LEO Pharma 2009-01-31
NCT00721487 Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections https://ClinicalTrials.gov/show/NCT00721487 Completed CPL Associates 2009-10-31
NCT00514358 Fluconazole Pharmacokinetics in Infants https://ClinicalTrials.gov/show/NCT00514358 Completed Children’s Hospital of Philadelphia 2007-06-30
NCT00388167 Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection https://ClinicalTrials.gov/show/NCT00388167 Completed PETHEMA Foundation NA
NCT00368784 T Cell Repertoire Analysis of Immune Mediated Skin Diseases https://ClinicalTrials.gov/show/NCT00368784 Recruiting University of California, Davis 2021-10-31
NCT00342589 New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia https://ClinicalTrials.gov/show/NCT00342589 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00254332 Effect of Denileukin Diftitox on Immune System in CTCL Patients https://ClinicalTrials.gov/show/NCT00254332 Completed FDA Office of Orphan Products Development NA
NCT00230243 Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387) https://ClinicalTrials.gov/show/NCT00230243 Completed Merck Sharp & Dohme Corp. 2002-09-30
NCT00177944 Invasive Fungal Infections Surveillance Initiative https://ClinicalTrials.gov/show/NCT00177944 Completed University of Pittsburgh 2012-08-31
NCT00177788 Voriconazole as Prophylaxis for Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT00177788 Completed University of Pittsburgh 2012-08-31
NCT00177268 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research https://ClinicalTrials.gov/show/NCT00177268 Recruiting University of Pittsburgh 2027-01-31
NCT00177190 In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) https://ClinicalTrials.gov/show/NCT00177190 Completed University of Pittsburgh 2005-01-31
NCT00026767 Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT00026767 Completed National Institutes of Health Clinical Center (CC) NA
NCT00721578 A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections https://ClinicalTrials.gov/show/NCT00721578 Completed Pfizer 2009-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03676777 Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China https://ClinicalTrials.gov/show/NCT03676777 Recruiting Ruijin Hospital 2019-12-31
NCT03174457 Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study https://ClinicalTrials.gov/show/NCT03174457 Completed Astellas Pharma Inc 2018-05-31
NCT02296164 Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma https://ClinicalTrials.gov/show/NCT02296164 Completed Helsinn Therapeutics (U.S.), Inc 2018-10-17
NCT01829204 Prospective Data Bank Creation to Study Vaginal Conditions https://ClinicalTrials.gov/show/NCT01829204 Recruiting Texas Tech University Health Sciences Center 2020-07-31
NCT04024995 Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies https://ClinicalTrials.gov/show/NCT04024995 Recruiting Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 2020-03-31